Cargando…
Drug-Coated Balloon-Only Strategy for De Novo Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials
BACKGROUNDS: Many clinical trials have demonstrated the value of drug-coated balloons (DCB) for in-stent restenosis. However, their role in de novo lesions is not well documented. The aim of this study is to evaluate the safety and efficacy of the DCB-only strategy compared to other percutaneous cor...
Autores principales: | Zhang, Wenyi, Zhang, Mingduo, Tian, Jinfan, Zhang, Min, Zhou, Yuan, Song, Xiantao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427238/ https://www.ncbi.nlm.nih.gov/pubmed/37588774 http://dx.doi.org/10.1155/2023/3121601 |
Ejemplares similares
-
Drug Coated Balloon-Only Strategy in De Novo Lesions of Large Coronary Vessels
por: Rosenberg, Mark, et al.
Publicado: (2019) -
The Drug Coated Balloon-Only Strategy for Treatment of de Novo Left
Main Coronary Artery Bifurcation Lesion: Stentless Strategy
por: Liu, Hengdao, et al.
Publicado: (2022) -
Efficacy and safety of drug-coated balloons in the treatment of de novo coronary lesions in very small vessels: a prospective, multicenter, single-arm trial
por: Zhang, Mingduo, et al.
Publicado: (2022) -
Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes
por: Cui, Kongyong, et al.
Publicado: (2019) -
Long-Term Clinical Outcomes After Percutaneous Coronary Intervention With Drug-Coated Balloon-Only Strategy in de novo Lesions of Large Coronary Arteries
por: Hu, Feng-Wang, et al.
Publicado: (2022)